All news

Search here results

• World first trial for patients with progressive MS launches in the UK | UCL Queen Square Institute of Neurology - UCL – University College London
• Can MRI scans predict MS progression? | UCL Queen Square Institute of Neurology - UCL – University College London
• Queen Square Analytics launch: developing breakthrough imaging analysis technology for trials | UCL Queen Square Institute of Neurology - UCL – University College London
• New MRI techniques could pave way to predict disability in multiple sclerosis | UCL Queen Square Institute of Neurology - UCL – University College London
• New multiple sclerosis subtypes identified using artificial intelligence | UCL Queen Square Institute of Neurology - UCL – University College London
• Human story of MS research | UCL Queen Square Institute of Neurology - UCL – University College London
• Results of a ‘3 in 1’ trial for Progressive MS published | UCL Queen Square Institute of Neurology - UCL – University College London
• Recruitment for the MS-STAT2 trial at UCL reaches over 200 participants | UCL Queen Square Institute of Neurology - UCL – University College London
• Early MRI scans could predict multiple sclerosis disability | UCL Queen Square Institute of Neurology - UCL – University College London
• Statins’ potential to treat MS unrelated to lowering cholesterol | UCL Queen Square Institute of Neurology - UCL – University College London